The Skin Cancer Foundation Official Website
The Skin Cancer Foundation saves and improves lives. We empower people to take a proactive approach to daily sun protection and the early detection and treatment of skin cancer.
Related Articles
SurgOnc Today® – Society of Surgical Oncology
SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their…
Jill Barnholtz-Sloan joins Emory Winship as chief administrative officer – The Cancer Letter
Jill S. Barnholtz-Sloan was appointed chief administrative officer and associate director for research administration at Winship Cancer Institute of Emory University, effective July 21. To…
SAFE Sunscreen Standards Act
The Skin Cancer Foundation and Refinery29 are teaming up to save lives. Sign the petition telling the FDA to ban teen tanning.
The Skin Cancer Foundation (@skincancerorg) • Instagram photos and videos
389 likes, 23 comments – skincancerorg on July 16, 2025: “📢 URGENT CALL FOR ADVOCACY! SAFE Sunscreen Standards Act. Sign the Letter of…
Clinical Education Conference
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals…
Tenosynovial Giant Cell Tumor (TGCT)
Tenosynovial giant cell tumor (TGCT) is a rare benign tumor involving the joint synovium, bursae, and tendon sheath.
American Cancer Society nutrition and physical activity guideline for cancer survivors
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Novel CDK2 Inhibitor INCB123667 Shows Promise in Ovarian Cancer
The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.
Impact of Industry Collaboration on US Food and Drug Administration Approval Success in Genitourinary Malignancy Phase III Clinical Trials | JCO Oncology Practice
PURPOSECollaboration among trial sponsors can pool expertise and resources, potentially accelerating drug development and regulatory success. This study assessed whether collaborations between drug sponsors influence…
Neoadjuvant ablative radiotherapy + chemo reduces risk of pancreatic cancer regrowth, stimulates immune system, cohort study finds – The Cancer Letter
Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing the rate of recurrence after treatment, according to a…